This spring, progress is taking shape across every part of our work. From advancing research to expanding programs that reach more patients than ever before, we are helping hope bloom. […]
Keeping Patients Moving Forward: CancerCare’s 2025 Year-End Impact
Since 1998, the Hirshberg Foundation has partnered with CancerCare to help families navigate the financial and emotional challenges that follow a pancreatic cancer diagnosis. With your generosity, we provide bi-annual […]
Promising results combining immunotherapy and chemotherapy before surgery in pancreatic cancer
A recent study published in Nature Communications, sponsored by the UCLA Health Jonsson Comprehensive Cancer Center, showed that adding immunotherapy to standard chemotherapy, before surgery, may benefit a subset of […]
Hirshberg Foundation Launches PNET Pathway Grant Program to Accelerate Research
The Hirshberg Foundation for Pancreatic Cancer Research is proud to announce the launch of the PNET Pathway Grant Program, a new research initiative focused on accelerating discoveries in pancreatic neuroendocrine […]
pNET Treatments and Emerging Research
As an overview of Pancreatic Neuroendocrine Tumors, we look at the current standard treatment for pNETs and what emerging therapies are on the horizon. Also discussed is the translational research […]
What is a Pancreatic Neuroendocrine Tumor?
Pancreatic neuroendocrine tumors, also called pNETs or PanNETs, are the second most common type of pancreatic tumor, representing up to 2% of all pancreatic cancer cases. pNETs are distinct from […]